- Oncor Inc., of Gaithersburg, Md., received a $720,000 Phase IISmall Business Innovation Research grant from the National Institutesof Health for molecular analysis of human chromosomes. Thecompany said the funds will be used to develop genetic probes to helpdetect chromosome rearrangements associated with genetic diseases.- Agis Pharmaceuticals, of Houston, now calls itself SENNES DrugInnovations Inc. The company said the new name reflects its focus oncell senescence genes and their applications for growth regulation,cancer and other proliferative disorders.

(c) 1997 American Health Consultants. All rights reserved.